Skip to main content
PheKB
a knowledgebase for discovering phenotypes from electronic medical records
Login
Request Account
Menu
Toggle menu visibility
Home
Phenotypes
Public
Collaboration
Implementations
Resources
PheWAS Data Submission
Contact Us
User menu
Login
Request Account
Search
Implementations by Phenotype
Home
Phenotypes
Title
Phenotype
Institution
Algorithm Type
Total Cases
Total Controls
PPV
sort descending
Sensitivity
PAD Northwestern Implementation
Peripheral Arterial Disease - 2012
Northwestern University
Case, Control
0.95, 1.00
1.00, 0.82
Intellectual Disability
Intellectual Disability
Cincinnati Children's Hospital Medical Center
Case, Control
0.95, 0.95
Height Northwestern Implementation
Height
Northwestern University
Case Only
0.95
Sickle Cell Froedtert Hospital Implementation
Sickle Cell Disease
Froedtert Hospital
Case Only
0.96
0.98
AMI/1st AMI Vanderbilt Implementation
Statins and MACE
Vanderbilt University
Case Only
50
0.96
CHOP implementation
ADHD phenotype algorithm
CHOP
Case, Control
0.96, 0.96
Validation of Asthma Algorithm
Asthma
CHOP
Case, Control
0.96, 0.98
Cataracts Vanderbilt Implementation
Cataracts
Vanderbilt University
Case Only
0.96
Validation of Asthma algorithm - Marshfield
Asthma
Marshfield Clinic
Case, Control
0.96, 0.96
Atopic dermatitis implementation - Marshfield
Atopic Dermatitis Algorithm
Marshfield Clinic Research Foundation
Case, Control
0.96, 0.90
Asthma Algorithm Validation - CCHMC
Asthma
Cincinnati Children's Hospital Medical Center
Case, Control
0.96, 0.82
Group Health/University of Washington CAAD Implementation
CAAD (Carotid Artery Atherosclerosis Disease)
Group Health/University of Washington
Case, Control
300
4,475
0.96, 1.00
Vanderbilt Zoster Implementation
Herpes Zoster
Vanderbilt University
Case, Control
0.96, 1.00
Severe Early Childhood Obesity- CHOP
Severe Early Childhood Obesity
The Children's Hospital of Philadelphia
Case, Control
0.96, 0.96
CHOP Post-event Pain
Post-event Pain algorithm
CHOP
Case, Control
99
2
0.96
Statin and MACE Mount Sinai Implementation
Statins and MACE
Mount Sinai
Case Only
52
25
0.96, 1.00
1.00, 1.00
Geisinger caMRSA Implementation
caMRSA
Geisinger
Case, Control
25
25
0.96, 1.00
0.96
Group Halth/UW HF results as secondary site
Heart Failure (HF) with Differentiation between Preserved and Reduced Ejection Fraction
Group Health/UW
Case, Control
771
1,010
0.96, 1.00
RBC Marshfield Implementation
Red Blood Cell Indices
Marshfield Clinic Research Foundation
Case Only
0.96
0.87
Cardiac Conduction Northwestern Implementation
Cardiac Conduction (QRS)
Northwestern University
Case Only
0.97
0.97
Demonstration Project RA Implementation
Rheumatoid Arthritis - Demonstration Project
Vanderbilt University
Case, Control
0.97, 1.00
Cardiac Conduction Vanderbilt Implementation
Cardiac Conduction (QRS)
Vanderbilt University
Case Only
103
0.97
Geisinger eMERGE3 Combined Implementation
Diverticulosis and Diverticulitis
Geisinger
Case, Control
0.97, 0.94
Hypothyroidism Marshfield Implementation
Hypothyroidism
Marshfield Clinic Research Foundation
Case, Control
0.97, 1.00
1.00
Validation on 75 RA patients
Identification of Fibromyalgia Patients in a Rheumatoid Arthritis Cohort
Vanderbilt University
Case Only
0.97
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
next ›
last »